The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vincristine     Quarter: 2016Q3

Total Records: 1,179     Number of Pages: 59

DRUGNAME PT EventCount
VINCRISTINE Decreased appetite 13
VINCRISTINE Disease recurrence 13
VINCRISTINE Pancytopenia 13
VINCRISTINE SULFATE. Diffuse large B-cell lymphoma 13
VINCRISTINE Alopecia 12
VINCRISTINE Lower respiratory tract infection 12
VINCRISTINE Thrombosis 12
VINCRISTINE SULFATE. Hypotension 12
VINCRISTINE Pulmonary embolism 11
VINCRISTINE Stomatitis 11
VINCRISTINE Weight decreased 11
VINCRISTINE White blood cell count decreased 11
VINCRISTINE SULFATE. Kidney infection 11
VINCRISTINE SULFATE. Multiple organ dysfunction syndrome 11
VINCRISTINE SULFATE. Pancytopenia 11
VINCRISTINE Blood lactic acid increased 10
VINCRISTINE Dyspnoea 10
Vincristine Pleural effusion 10
VINCRISTINE Respiratory failure 10
vincristine Septic shock 10

Total Records: 1,179     Number of Pages: 59